ADVFN US – Market Content Editor

  • ENvue Medical expands U.S. hospital footprint to 39 sites with Detroit system purchase

    ENvue Medical expands U.S. hospital footprint to 39 sites with Detroit system purchase

    ENvue Medical, Inc. (NASDAQ:FEED) announced Monday that a 714-bed teaching hospital and Level I Trauma Center in the Detroit metropolitan area has purchased its ENvue Navigation Platform system along with compatible feeding tubes. The acquisition expands the company’s presence within a Southeast Michigan health system where its technology has previously been deployed, increasing ENvue’s total…

  • Robin Energy launches tender offer to repurchase up to 1M shares at $3

    Robin Energy launches tender offer to repurchase up to 1M shares at $3

    Robin Energy Ltd. (NASDAQ:RBNE) announced it will begin a tender offer to buy back up to 1,000,000 shares of its common stock, along with associated preferred share purchase rights, at a price of $3.00 per share. The offer represents a substantial premium compared with the company’s current share price of about $1.10, which is close…

  • RenX to implement 1-for-20 reverse stock split starting March 26

    RenX to implement 1-for-20 reverse stock split starting March 26

    RenX Enterprises Corp. (NASDAQ:RENX) announced it will carry out a 1-for-20 reverse stock split of its common shares, which will take effect at 12:01 a.m. Eastern Time on March 26, according to a company press release. Trading of the company’s stock on the Nasdaq Capital Market will begin on a split-adjusted basis when markets open…

  • Erayak pivots toward high-capacity power systems to serve AI infrastructure demand

    Erayak pivots toward high-capacity power systems to serve AI infrastructure demand

    Erayak Power Solution Group Inc. (NASDAQ:RAYA) announced a strategic shift toward developing high-capacity power solutions aimed at supporting artificial intelligence infrastructure in North America, according to a company press release. The company’s shares currently trade around $0.64, giving it a market capitalization of roughly $2.28 million, after a steep decline over the past year tied…

  • 20/20 BioLabs licenses kidney disease prediction technology from ROKIT Healthcare

    20/20 BioLabs licenses kidney disease prediction technology from ROKIT Healthcare

    20/20 BioLabs, Inc. (NASDAQ:AIDX) announced it has signed an exclusive U.S. technology licensing and access agreement with ROKIT Healthcare Inc. (KOSDAQ), according to a company press release. Under the arrangement, 20/20 BioLabs will incorporate ROKIT’s chronic kidney disease prediction algorithm into its 20/20 Longevity Platform. In return, ROKIT will reimburse one-third of the companies’ mutually…

  • Radiopharm reports 90% concordance in interim results for RAD 101 brain metastases trial

    Radiopharm reports 90% concordance in interim results for RAD 101 brain metastases trial

    Radiopharm Theranostics (NASDAQ:RADX) announced interim findings from its Phase 2b clinical trial evaluating RAD 101, an imaging agent designed to detect recurrent brain metastases, according to a company press release. The second interim analysis, which included 20 patients, showed that 90% achieved concordance between PET imaging results and MRI scans, meeting the study’s primary endpoint.…

  • CrowdStrike expands Falcon Flex model to include cybersecurity services

    CrowdStrike expands Falcon Flex model to include cybersecurity services

    CrowdStrike Holdings Inc. (NASDAQ:CRWD) announced the introduction of Flex for Services, extending its Falcon Flex licensing model to cover its cybersecurity services portfolio. The company also unveiled a Zero Dollar Flex Fund designed for eligible new customers. Under the Flex for Services model, organizations can access offerings such as threat hunting, red teaming, readiness assessments,…

  • ImmunityBio shares slide after FDA warning over misleading ANKTIVA promotion

    ImmunityBio shares slide after FDA warning over misleading ANKTIVA promotion

    ImmunityBio Inc. (NASDAQ:IBRX) shares dropped 15% on Tuesday after the U.S. Food and Drug Administration issued a warning letter citing misleading promotional materials related to the company’s bladder cancer therapy, ANKTIVA. The FDA’s Office of Prescription Drug Promotion said a television advertisement and a podcast featuring company executives included inaccurate claims regarding the drug’s effectiveness…

  • AWS develops AI tools to automate sales support functions – report

    AWS develops AI tools to automate sales support functions – report

    Amazon Web Services (NASDAQ:AMZN) is building new artificial intelligence technology aimed at automating tasks across its sales and business development teams, according to a report from The Information. The report, which cited two people familiar with the project, said AWS is developing an AI agent designed to help sales staff quickly respond to technical questions…

  • Apollo shares fall as concerns over private credit market grow

    Apollo shares fall as concerns over private credit market grow

    Shares of Apollo Global Management (NYSE:APO) dropped more than 3% in premarket trading on Tuesday as renewed worries about the health of the $2 trillion private credit market weighed on investor sentiment. The firm recently moved to limit investor withdrawals from one of its funds. Apollo’s stock has declined about 23.9% since the start of…